The drugmaker plans to acquire 33 percent stake in Avenue Therapeutics for $35 million at $6 per share, according to its stock exchange notification.
Shares of the pharmaceutical company fluctuated between gains and losses to trade at Rs 528.40.
The drugmaker plans to acquire 33 percent stake in Avenue Therapeutics for $35 million at $6 per share, according to its stock exchange notification.
Shares of the pharmaceutical company fluctuated between gains and losses to trade at Rs 528.40.